Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens.

por A'Hern, R. P., Smith, I. E., Ebbs, S. R.
Publicado 1993

Does chemotherapy improve survival in advanced breast cancer? A statistical overview.

por A'Hern, R. P., Ebbs, S. R., Baum, M. B.
Publicado 1988

Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.

por Fraser, S. C., Dobbs, H. J., Ebbs, S. R., Fallowfield, L. J., Bates, T., Baum, M.
Publicado 1993

Response of breast carcinoma to endocrine therapy predicted using immunostained pelleted fine needle aspirates.

por Heyderman, E., Ebbs, S. R., Larkin, S. E., Brown, B. M., Haines, A. M., Bates, T.
Publicado 1989

A daily diary for quality of life measurement in advanced breast cancer trials.

por Fraser, S. C., Ramirez, A. J., Ebbs, S. R., Fallowfield, L. J., Dobbs, H. J., Richards, M. A., Bates, T., Baum, M.
Publicado 1993

Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts.

por Colletta, A. A., Wakefield, L. M., Howell, F. V., van Roozendaal, K. E., Danielpour, D., Ebbs, S. R., Sporn, M. B., Baum, M.
Publicado 1990

Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer

por Archer, C D, Parton, M, Smith, I E, Ellis, P A, Salter, J, Ashley, S, Gui, G, Sacks, N, Ebbs, S R, Allum, W, Nasiri, N, Dowsett, M
Publicado 2003